Journal
JOURNAL OF MEDICAL GENETICS
Volume 46, Issue 4, Pages 242-248Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jmg.2008.059907
Keywords
-
Categories
Funding
- Children's Tumor Foundation
- Ruth L Kirschstein National Research Service Award
- National Institutes of Health [P01-GM061354]
- NARSAD Distinguished Investigator Award
- Harvard Scholars in Clinical Science [RRO22292-07]
- Autism Consortium and the Ellison Foundation
- NIH-CETT Program
- MDA Foundation
Ask authors/readers for more resources
Background: Segmental duplications at breakpoints (BP4-BP5) of chromosome 15q13.2q13.3 mediate a recurrent genomic imbalance syndrome associated with mental retardation, epilepsy, and/or electroencephalogram (EEG) abnormalities. Patients: DNA samples from 1445 unrelated patients submitted consecutively for clinical array comparative genomic hybridisation (CGH) testing at Children's Hospital Boston and DNA samples from 1441 individuals with autism from 751 families in the Autism Genetic Resource Exchange (AGRE) repository. Results: We report the clinical features of five patients with a BP4-BP5 deletion, three with a BP4-BP5 duplication, and two with an overlapping but smaller duplication identified by whole genome high resolution oligonucleotide array CGH. These BP4-BP5 deletion cases exhibit minor dysmorphic features, significant expressive language deficits, and a spectrum of neuropsychiatric impairments that include autism spectrum disorder, attention deficit hyperactivity disorder, anxiety disorder, and mood disorder. Cognitive impairment varied from moderate mental retardation to normal IQ with learning disability. BP4-BP5 covers similar to 1.5 Mb (chr15: 28.719-30.298 Mb) and includes six reference genes and 1 miRNA gene, while the smaller duplications cover similar to 500 kb (chr15: 28.902-29.404 Mb) and contain three reference genes and one miRNA gene. The BP4-BP5 deletion and duplication events span CHRNA7, a candidate gene for seizures. However, none of these individuals reported here have epilepsy, although two have an abnormal EEG. Conclusions: The phenotype of chromosome 15q13.2q13.3 BP4-BP5 microdeletion/duplication syndrome may include features of autism spectrum disorder, a variety of neuropsychiatric disorders, and cognitive impairment. Recognition of this broader phenotype has implications for clinical diagnostic testing and efforts to understand the underlying aetiology of this syndrome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available